In vivo metabolism of the cardiovascular toxin, allylamine.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Biochemical Pharmacology

• Publication date

  1987-12-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(87)90683-6PMID 3689456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vitro Expression of Benzylamine Oxidase Activity in Cultured Porcine Smooth Muscle Cells

  1987cited by this paper
• Biologically active intermediates generated by the reduced glutathione conjugation pathway. Toxicological implications.

  1986cited by this paper
• Vascular smooth muscle cells: a major source of the semicarbazide‐sensitive amine oxidase of the rat aorta

  1985cited by this paper
• A critical review of the literature on acrolein toxicity.

  1985cited by this paper
• Allylamine cardiovascular toxicity: V. Tissue distribution and toxicokinetics after oral administration.

  1985cited by this paper
• Electron impact mass spectrometric analysis of mercapturic acid methyl esters: fragmentation of mercapturic acid methyl esters according to retro-Michael reactions

  1983cited by this paper
• Biotransformation of the cardiovascular toxin, allylamine, by rat and human cardiovascular tissue.

  1982cited by this paper
• Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues.

  1982cited by this paper
• Correlation of proton chemical shifts by two-dimensional Fourier transform NMR

  1981cited by this paper
• Allylamine cardiotoxicity: II. Histopathology and histochemistry.

  1980cited by this paper
• Allylamine cardiotoxicity: I. Sequence of pathologic events.

  1979cited by this paper
• Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.

  1979cited by this paper
• Practice of Thin Layer Chromatography

  1978cited by this paper
• A fluorometric method for determination of oxidized and reduced glutathione in tissues.

  1976cited by this paper
• Studies on the in vivo formation of acrolein: 3-hydroxy-propylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation.

  1976cited by this paper
• Biosynthesis of mercapturic acids from allyl alcohol, allyl esters and acrolein.

  1973cited by this paper
• Conversion of allyl alcohol into acrolein by rat liver.

  1972cited by this paper
• Myocardial fibrosis and smooth muscle cell hyperplasia in coronary arteries of allylamine-fed rats.

  1972cited by this paper
• The synthesis of mercapturic acids from allyl compounds in the rat.

  1972cited by this paper
• The metabolic formation of mercapturic acids from allyl halides.

  1972cited by this paper
• Factors which contribute to aortic fibrous repair in rats fed beta-aminopropionitrile.

  1970cited by this paper
• Coronary artery hyalinosis in rats fed allylamine.

  1969cited by this paper
• The formation of 2-hydroxypropylmercapturic acid from 1-halogenopropanes in the rat.

  1966cited by this paper
• Production of Coronary Heart Disease in the Rabbit by Lanolin Feeding

  1957cited by this paper
• Changes in the coronary arteries of the dog following injections of allylamine.

  1948cited by this paper

• The Role of Acrolein in Neurodegenerative Diseases and Its Protective Strategy

  2022cites this paper
• Acrolein and Human Disease: Untangling the Knotty Exposure Scenarios Accompanying Several Diverse Disorders.

  2017cites this paper
• Optical Imaging Biomarkers of Drug-Induced Vascular Injury

  2015cites this paper
• Papel das aminoxídases sensíveis à semicarbazina (SSAO) na regulação da pressão arterial e do stresse oxidativo vascular e renal

  2014cites this paper
• Managing the liabilities arising from structural alerts: a safe philosophy for medicinal chemists.

  2011cites this paper
• Acrolein health effects

  2008cites this paper
• Toxicological profile for acrolein

  2007cites this paper
• Quantitative urinalysis of the mercapturic acid conjugates of allyl formate using high-resolution NMR spectroscopy.

  2006cites this paper
• Glutathione S-Transferases and Oxidative Injury of Cardiovascular Tissues

  2006cites this paper
• Visit the National Academies Press online, the authoritative source for all books from the National Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, and the National Research Council: • Download hundreds of free books in PDF

  2005cites this paper
• Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products.

  2002cites this paper
• Amine metabolism: a novel path to coronary artery vasospasm.

  2001cites this paper
• N8‐acetyl spermidine protects rat cerebellar granule cells from low K+‐induced apoptosis

  1999cites this paper
• Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro.

  1999cites this paper
• Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.

  1998cites this paper
• The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall.

  1998cites this paper
• Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes.

  1998cites this paper
• Metabolism and Distribution of [2,3‐14C]Acrolein in Sprague‐Dawley Rats

  1996cites this paper
• Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects.

  1996cites this paper
• Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury.

  1996cites this paper
• Substrate-specificity of mammalian tissue-bound semicarbazide-sensitive amine oxidase.

  1995cites this paper
• Glutathione S-transferase 8-8 is localized in smooth muscle cells of rat aorta and is induced in an experimental model of atherosclerosis.

  1995cites this paper
• Mechanism of reaction of allylamine with the quinoprotein methylamine dehydrogenase.

  1995cites this paper
• Chemical-induced vasculature injury. Summary of the symposium presented at the 32nd annual meeting of the Society of Toxicology, New Orleans, Louisiana, March 1993.

  1995cites this paper
• Vascular amine oxidase activities during synergistic vasculotoxicity.

  1994cites this paper
• Lipid peroxidation and oxidative stress during acute allylamine-induced cardiovascular toxicity.

  1994cites this paper
• Properties of mammalian tissue-bound semicarbazide-sensitive amine oxidase: possible clues to its physiological function?

  1994cites this paper
• Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine.

  1993cites this paper
• Oxidative Deamination of Methylamine by Semicarbazide-Sensitive Amine Oxidase Leads to Cytotoxic Damage in Endothelial Cells: Possible Consequences for Diabetes

  1993cites this paper
• One‐year toxicity of orally administered acrolein to the beagle dog

  1992cites this paper
• Properties and functions of the semicarbazide-sensitive amine oxidases.

  1991cites this paper
• Allylamine and acrolein toxicity in perfused rat hearts.

  1991cites this paper
• Comparative angiotoxic responses of avian and rodent species in vivo: implications in atherogenesis.

  1990cites this paper
• Inhibition of rat heart mitochondrial electron transport in vitro: implications for the cardiotoxic action of allylamine or its primary metabolite, acrolein.

  1990cites this paper
• Evaluation of N-acetylcysteine and methylprednisolone as therapies for oxygen and acrolein-induced lung damage.

  1990cites this paper
• Allylamine and beta-aminopropionitrile-induced vascular injury: an in vivo and in vitro study.

  1990cites this paper
• Allylamine and β-aminopropionitrile-induced vascular injury: An in vivo and in vitro study

  1990cites this paper
• 1.1 – Allylamine

  1990cites this paper
• 3‐Hydroxypropylmercapturic acid: A biologic marker of exposure to allylic and related compounds

  1989cites this paper